Article

Eye drop royalties benefit Schepens research

Woburn, MA-Advanced Vision Research Inc.'s royalty payments have made it the single largest private benefactor of The Schepens Eye Research Institute.

Woburn, MA-Advanced Vision Research Inc.'s royalty payments have made it the single largest private benefactor of The Schepens Eye Research Institute.

The company has paid more than $1.5 million to the institute as part of its agreement to license the patents developed there by Jeffrey P. Gilbard, MD.

Dr. Gilbard studied dry eye while at the institute from 1980 to 1995, and developed the TheraTears Brand Lubricant Eye Drops as a result of an 18-year research project funded by the National Institutes of Health. He went on to found Advanced Vision Research, and serves as its chief executive officer and chief scientific officer.

Related Videos
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.